Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells.
On the sex ratio of multiple sclerosis.
Atomic structures of amyloid cross-beta spines reveal varied steric zippers.
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment.
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy.
Complications of Immunosuppressive/Immunomodulatory Therapy in Neurological Diseases.
Towards a Classification Approach using Meta-Biclustering: Impact of Discretization in the Analysis of Expression Time Series.
Diverse functional roles of lipocalin-2 in the central nervous system.
Immunological differences between classical phenothypes of multiple sclerosis.
Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis?
Cyclophosphamide in chronic progressive multiple sclerosis: a comparative study.
Natalizumab adverse events are rare in patients with multiple sclerosis.
Human neural precursor cells promote neurologic recovery in a viral model of multiple sclerosis.
Closing the clinical-radiological paradox using the visual pathway in multiple sclerosis.
Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological Disorders.
Ethical challenges in paediatric clinical trials in multiple sclerosis.
Curcumin Serves as a Human Kv1.3 Blocker to Inhibit Effector Memory T Lymphocyte Activities.
Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial.
[Marihuana and cannobinoids as medicaments].
Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis.
Dendritic cells and multiple sclerosis: disease, tolerance and therapy.
Biomarkers of treatment response in multiple sclerosis.
Impact of Clear, Loud and Slow Speech on Scaled Intelligibility and Speech Severity in Parkinson's Disease and Multiple Sclerosis.
ApoTransferrin: Dual Role on Adult Subventricular Zone-Derived Neurospheres.
Pages
« first
‹ previous
…
243
244
245
246
247
248
249
250
251
…
next ›
last »